COVID-19 pandemic: Guidance for Add-Aspirin participants
In the current pandemic situation, we know that trial participants may have concerns or questions about taking their trial treatment and attending follow-up appointments. We have provided some general guidance here.
Add-Aspirin
Can taking daily aspirin after treatment for cancer stop or delay the cancer from coming back?
Welcome to Add-Aspirin
This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.
Add-Aspirin is a large randomised clinical trial, which is taking place in the UK, Republic of Ireland and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.
Congratulations to our top 5 recruiting centres:
- University Hospitals Coventry & Warwickshire
- Tata Memorial Hospital, Mumbai
- Worcestershire Royal Hospital
- Royal Marsden Hospitals
- Queen Elizabeth Hospital, King's Lynn
*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*
News
Re-opening Trial Recruitment in the UK and ROI
We’re pleased to announce that we are now in a position to re-open trial recruitment in the UK and ROI in those centres that have the capacity to begin registering patients again. Please refer to the updated guidance found here if your centre is in a position to restart recruitment.
Congratulations to Kettering General Hospital who have registered the first patient following the suspension to the colorectal cohort.
_____________________________________
Updated guidance on use of NSAIDs and Covid-19
Please read our latest guidance on non-steroidal anti-inflammatory drugs (NSAIDs) and Covid-19 here.
Quick Links
From Monday 16th March 2020, to RANDOMISE a participant from the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
Unblind a participant in the UK
Breast
We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.
CURRENT RECRUITMENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: Tata Memorial Hospital Mumbai, Western General Hospital, Worcestershire Royal Hospital, Churchill Hospital Oxford
PARTICIPANTS REGISTERED: 3704
PARTICIPANTS RANDOMISED: 3184
Colon/Rectum
We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer.
CURRENT RECRUITMENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: St James's University Hospital, Western General Hospital, Bristol Haematology & Oncology Centre, Velindre Hospital
PARTICIPANTS REGISTERED: 2223
PARTICIPANTS RANDOMISED: 1873
Gastro
We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).
CURRENT RECRUITMENT STATUS: OPEN
Detailed eligibility criteria available here
Top recruiters: Tata Memorial Hospital Mumbai, Christie Hospital, Cancer Institute (WIA), UHCW, St James's University Hospital
PARTICIPANTS REGISTERED: 481
PARTICIPANTS RANDOMISED: 399
Prostate
We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.
CURRENT RECRUITMENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: UHCW, Darent Valley Hospital, Queen Elizabeth Hospital King's Lynn, University Hospital of Wales
PARTICIPANTS REGISTERED: 1792
PARTICIPANTS RANDOMISED: 1567
the trial is being jointly funded by
